T1	Participants 0 159	Comparative study of the efficacy of eprinomectin versus ivermectin, and field efficacy of eprinomectin only, for the treatment of chorioptic mange in alpacas.
T2	Participants 494 547	Thirty alpacas, all positive for Chorioptes sp. mite,
T3	Participants 575 606	two treatment groups in Study 1
T4	Participants 698 724	the dose rate of 500mug/kg
T5	Participants 835 861	the dose rate of 400mug/kg
T6	Participants 863 946	Response to treatment was assessed by periodic mite count, and skin lesions scored.
T7	Participants 947 1142	In Study 2, one group of 19 alpacas received four administrations at weekly interval of topical eprinomectin at the dose rate of 500mug/kg, and response to treatment was monitored by mite counts.
T8	Participants 1625 1842	The eprinomectin protocol employed in Study 2, consisting of four weekly topical administrations at the dose rate of 500mug/kg of body weight, proved highly effective at reducing the Chorioptes mite burden in alpacas.
